As a KOSPI-listed company, Pulmuone discloses corporate financial and non-financial information in business reports, integrated reports, and on its website to guarantee shareholders' right to know.

Following the 5th Regular Board of Directors resolution on December 6, 2024, the appointment of the Group CEO as representative director was approved, and Representative Director Lee Woo-bong was appointed in January 2025.

Accordingly, information as of the end of December 2024 is disclosed together for information disclosure to stakeholders. (Current major shareholder status and management stock ownership status can be found on pages 116 and 134 of the integrated report, respectively.)

[As of the end of December 2024]

1) Nam Seung-woo, Lee Sang-yoon, Lee Woo-bong, Kim Jin-hong, Park Gwang-soon, Won Hye-young, Kim Young-hwan, Kim Jong-heon, Lee Soo-yeon, Kim Woo-jin, Yu Tae-sang